220 related articles for article (PubMed ID: 23718932)
1. The effect of statins on risk and survival of gynecological malignancies.
Lavie O; Pinchev M; Rennert HS; Segev Y; Rennert G
Gynecol Oncol; 2013 Sep; 130(3):615-9. PubMed ID: 23718932
[TBL] [Abstract][Full Text] [Related]
2. The effect of bisphosphonates on the risk of endometrial and ovarian malignancies.
Rennert G; Rennert HS; Pinchev M; Lavie O
Gynecol Oncol; 2014 May; 133(2):309-13. PubMed ID: 24556062
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
4. An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.
Desai P; Wallace R; Anderson ML; Howard BV; Ray RM; Wu C; Safford M; Martin LW; Rohan T; Manson JE; Simon MS
Gynecol Oncol; 2018 Mar; 148(3):540-546. PubMed ID: 29422345
[TBL] [Abstract][Full Text] [Related]
5. Gynecological malignancy risk in colorectal cancer survivors: A population-based cohort study.
Chang WC; Muo CH; Liang JA; Sung FC; Kao CH
Eur J Oncol Nurs; 2015 Oct; 19(5):473-8. PubMed ID: 25790918
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease.
Ludvigsson JF; West J; Ekbom A; Stephansson O
Int J Cancer; 2012 Aug; 131(3):E244-50. PubMed ID: 21953605
[TBL] [Abstract][Full Text] [Related]
9. Risks of breast, endometrial, and ovarian cancers after twin births.
Ji J; Försti A; Sundquist J; Hemminki K
Endocr Relat Cancer; 2007 Sep; 14(3):703-11. PubMed ID: 17914100
[TBL] [Abstract][Full Text] [Related]
10. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
Liu Y; Qin A; Li T; Qin X; Li S
Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
[TBL] [Abstract][Full Text] [Related]
11. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
Schoen RE; Weissfeld JL; Kuller LH
Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
[TBL] [Abstract][Full Text] [Related]
12. The effect of body mass index and weight change on epithelial ovarian cancer survival in younger women: a long-term follow-up study.
Tyler CP; Whiteman MK; Zapata LB; Hillis SD; Curtis KM; McDonald J; Wingo PA; Kulkarni A; Marchbanks PA
J Womens Health (Larchmt); 2012 Aug; 21(8):865-71. PubMed ID: 22663301
[TBL] [Abstract][Full Text] [Related]
13. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
14. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group.
Gruber SB; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):411-7. PubMed ID: 8781735
[TBL] [Abstract][Full Text] [Related]
15. Timing of pregnancy and the risk of epithelial ovarian cancer.
Whiteman DC; Siskind V; Purdie DM; Green AC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
[TBL] [Abstract][Full Text] [Related]
16. Statin use and female reproductive organ cancer risk in a large population-based setting.
Yu O; Boudreau DM; Buist DS; Miglioretti DL
Cancer Causes Control; 2009 Jul; 20(5):609-16. PubMed ID: 19043788
[TBL] [Abstract][Full Text] [Related]
17. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
18. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
19. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.
Chae YK; Valsecchi ME; Kim J; Bianchi AL; Khemasuwan D; Desai A; Tester W
Cancer Invest; 2011 Nov; 29(9):585-93. PubMed ID: 21936625
[TBL] [Abstract][Full Text] [Related]
20. Statin use and the risk of ovarian and endometrial cancers: a meta-analysis.
Wang Y; Ren F; Song Z; Chen P; Liu S; Ouyang L
BMC Cancer; 2019 Jul; 19(1):730. PubMed ID: 31340777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
